hydrocodone | Knowledge of Medicine

FDA panel backs more restricted hydrocodone prescribing

SILVER SPRING,MD. Vicodin,Norco,and other hydrocodone combination products should be reclassified as schedule II drugs,because stricter controls on prescribing are needed to address the current…

Rheumatology News

Panel votes against hydrocodone because of abuse potential

SILVER SPRING,MD. The majority of a Food and Drug Administration advisory panel voted against approval of an extended-release,single-ingredient capsule formulation of hydrocodone for the…

Rheumatology News

Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg:Recall –Potential for Oversized Tablets

Unintentional administration of tablets with increased acetaminophen content could result in liver toxicity. MedWatch Safety Alert RSS Feed

Pharmacy Groups Oppose Reclass of Hydrocodone

WASHINGTON (MedPage Today) —Pharmacy groups are voicing their opposition to an amendment in the Senate’s FDA user fee reauthorization bill that would reclassify all medications containing hydrocodone as Schedule II drugs. MedPageToday.com –medical news plus CME for physicians

FDA Approves Zutripro (hydrocodone bitartrate,chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution

MADISON,Miss.–(BUSINESS WIRE)–Jun 13,2011 –Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for Zutripro (hydrocodone bitartrate,chlorpheniramine maleate and…

Drugs.com –New Drug Approvals

FDA Approves Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution

MADISON,Miss.–(BUSINESS WIRE)–Jun 13,2011 –Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution…

Drugs.com –New Drug Approvals